Blog

In a groundbreaking study published on January 18, 2024, in Cancer Discovery, scientists at University of California San Diego School of Medicine leveraged a machine learning algorithm to tackle one of the biggest challenges facing cancer researchers: predicting when cancer will resist chemotherapy. Credit: National

“In the future, targeting of RBMX may be a novel method in cancer therapy.” Credit: 2024 Sheng et al. “In the future, targeting of RBMX may be a novel method in cancer therapy.” BUFFALO, NY- January 17, 2024 – A new research paper was published

“[…] this study identifies gartisertib as a potent ATRi within patient-derived glioblastoma cell lines.” Credit: 2024 Lozinski et al. “[…] this study identifies gartisertib as a potent ATRi within patient-derived glioblastoma cell lines.” BUFFALO, NY- January 17, 2024 – A new research paper was published

A new study reported that SARS-CoV-2, the virus that causes COVID, can infect dopamine neurons in the brain and trigger senescence—when a cell loses the ability to grow and divide. The researchers from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and Columbia University Vagelos

In diagnostics, finding more is not automatically better. Rather, it is about finding the right thing – especially in the case of such dangerous diseases as cancer. This is where early detection comes into play, but it can also have unwanted side effects: For example,

“Precision medicine,” an emerging approach to health care in which a patient’s genetics, diseased tissue and other factors guide clinicians to personalize treatment strategies, can dramatically improve health outcomes for people with various diseases, notably cancer. Credit: Photo provided by the University of Oklahoma Health

Copper is an essential trace element required to produce energy in the body and allows humans to live in our atmosphere. But research has found that increased accumulation of copper is associated with worse outcomes for patients with the most common type of kidney cancer

A team of melanoma researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) is honored with the 2023 Paper of the Year distinction by the Journal of Clinical Oncology. The recognition is for the results of the DREAMseq randomized phase 3 clinical trial. DREAMseq (EA6134) showed an

Osaka, Japan – Cytokines are chemical messengers that help the body get rid of invading bacteria and viruses, and control inflammation. The body carefully balances cytokines because they help keep the immune system healthy. However, this balance is upset if the immune system overreacts. A

What makes a soldier switch sides? That is a really good question. Especially when the soldier is an antibody that is supposed to defend the body against one of the world’s most dangerous snake venoms but instead ends up helping the venom kill the body.